Ramipril in the light of the HOPE trial

Abstract

HOPE trial (Heart Outcomes Prevention Evaluation) aimed at prognosis in patients with high cardiovascular risk treated with ACE inhibitor ramipril is a key study affecting clinical practice. The article summarizes study findings.

Keywords

• HOPE trial
• HOPE-TOO
• ramipril
• ACE inhibitors
• cardiovascular mortality
• diabetes mellitus